{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:29:07Z","timestamp":1762853347522,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.oret.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T14:01:57Z","timestamp":1530194517000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis"],"prefix":"10.1016","volume":"3","author":[{"given":"Akshay S.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco A.","family":"Folgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn J.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2018.05.004_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73813-9","article-title":"Course of vitreomacular traction syndrome","volume":"119","author":"Hikichi","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.05.004_bib2","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.05.004_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.03-0930","article-title":"Posterior vitreous detachment induced by microplasmin","volume":"45","author":"Gandorfer","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.05.004_bib4","first-page":"473","article-title":"Molecular biology of pharmacologic vitreolysis","volume":"103","author":"Sebag","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2018.05.004_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2018.05.004_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IAE.0b013e3182a15f8b","article-title":"Clinical course of vitreomacular adhesion managed by initial observation","volume":"34","author":"John","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00417-014-2826-9","article-title":"Evolution of vitreomacular adhesion to acute vitreofoveal separation with special emphasis on a traction-induced foveal pathology. A prospective study of spectral-domain optical coherence tomography","volume":"253","author":"Theodossiadis","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2018.05.004_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3928\/23258160-20150521-09","article-title":"Clinical course of vitreomacular traction managed initially by observation","volume":"46","author":"Tzu","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/IAE.0000000000001015","article-title":"Anatomical and functional outcomes of symptomatic idiopathic vitreomacular traction: a natural history study from the Pan American Collaborative Retina Study Group","volume":"36","author":"Wu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.iae.0000223758.17543.49","article-title":"Natural history of foveolar lucencies observed by optical coherence tomography after macular hole surgery","volume":"27","author":"Mahmoud","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ajo.2015.08.014","article-title":"Assessment of foveal microstructure and foveal lucencies using optical coherence tomography radial scans following macular hole surgery","volume":"160","author":"Grewal","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.05.004_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.oret.2016.11.013","article-title":"Recovery of foveal anatomy and subfoveal lucency after pharmacologic and surgical macular hole closure in the ocriplasmin phase III trials","volume":"1","author":"Folgar","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/IAE.0000000000000519","article-title":"Safety profile of ocriplasmin for symptomatic vitreomacular adhesion: a comprehensive analysis of premarketing and postmarketing experiences","volume":"35","author":"Hahn","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib14","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1167\/iovs.12-10379","article-title":"Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis","volume":"53","author":"Folgar","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.05.004_bib15","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1167\/iovs.13-11811","article-title":"Vitreous levels of active ocriplasmin following intravitreal injection: results of an ascending exposure trial","volume":"54","author":"Stalmans","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.05.004_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/IAE.0000000000000755","article-title":"Resolution of subretinal fluid and outer retinal changes in patients treated with ocriplasmin","volume":"36","author":"Nudleman","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","article-title":"Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome","volume":"98","author":"Singh","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2018.05.004_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/IAE.0000000000000544","article-title":"Outer retina reflectivity changes on SD-OCT after intravitreal ocriplasmin for vitreomacular traction and macular hole","volume":"35","author":"Quezada-Ruiz","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/eye.2013.94","article-title":"Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin","volume":"27","author":"Freund","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2018.05.004_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/ICB.0000000000000061","article-title":"Reversible vision loss and outer retinal abnormalities after intravitreal ocriplasmin injection","volume":"8","author":"Thanos","year":"2014","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2018.05.004_bib21","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.ophtha.2014.07.044","article-title":"Assessment of retinal alterations after intravitreal ocriplasmin with spectral-domain optical coherence tomography","volume":"121","author":"Itoh","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.05.004_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/IAE.0000000000000667","article-title":"Acute ocriplasmin retinopathy","volume":"35","author":"Johnson","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/IAE.0000000000000448","article-title":"Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion\/traction","volume":"35","author":"Kaiser","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib24","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1097\/IAE.0000000000001110","article-title":"Ellipsoid zone mapping and outer retinal characterization after intravitreal ocriplasmin","volume":"36","author":"Itoh","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.05.004_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3109\/02713680903308487","article-title":"Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy","volume":"34","author":"Chen","year":"2009","journal-title":"Curr Eye Res"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653018302276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653018302276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:25:21Z","timestamp":1762853121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653018302276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2468653018302276"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2018.05.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"type":"print","value":"2468-6530"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}